Gloriana Therapeutics Overview
- Year Founded
-
1999
- Status
-
Out of Business
- Employees
-
13
- Latest Deal Type
-
Out of Business
Gloriana Therapeutics General Information
Description
Developer of transformational therapeutics designed to provide treatment for neurological diseases. The company's therapeutics identify novel neurotrophic proteins with therapeutic effects in the nervous system and develop technologies to target protein therapeutics across the blood-brain barrier and directly to diseased nerve cells, enabling healthcare professionals to initiate treatment and potentially lead to a cure for neurological disorders.
Contact Information
Website
www.glorianatherapeutic.comCorporate Office
- 130 Franklin Street
- Warren, RI 02885
- United States
Corporate Office
- 130 Franklin Street
- Warren, RI 02885
- United States
Gloriana Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Out of Business | 17-Sep-2024 | Completed | Out of Business | |||
| 12. Later Stage VC | 29-Nov-2019 | Cancelled | Product Development | |||
| 11. Secondary Transaction - Private | 01-Nov-2017 | Completed | Product Development | |||
| 10. Grant | 21-Nov-2013 | Completed | Product Development | |||
| 9. Later Stage VC | 01-Dec-2009 | Completed | Product Development | |||
| 8. Later Stage VC | 20-May-2008 | Completed | Product Development | |||
| 7. Later Stage VC | 02-May-2005 | Completed | Product Development | |||
| 6. Grant | 07-Jul-2004 | Completed | Product Development | |||
| 5. Later Stage VC | 05-Jan-2004 | $2.98M | $19.4M | Completed | Product Development | |
| 4. Early Stage VC | 29-Dec-2003 | $2.98M | $16.4M | Completed | Startup |
Gloriana Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| D Shares |
Gloriana Therapeutics Patents
Gloriana Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020417255-A1 | Mammalian cells secreting gdnf and their therapeutic use | Inactive | 29-Dec-2019 | ||
| CA-3163253-A1 | Mammalian cells secreting gdnf and their therapeutic use | Active | 29-Dec-2019 | ||
| CA-3163253-C | Mammalian cells secreting gdnf and their therapeutic use | Active | 29-Dec-2019 | ||
| EP-4081262-A1 | Mammalian cells secreting gdnf and their therapeutic use | Inactive | 29-Dec-2019 | ||
| EP-4081262-A4 | Mammalian cells secreting gdnf and their therapeutic use | Inactive | 29-Dec-2019 | C12M25/02 |
Gloriana Therapeutics Signals
Gloriana Therapeutics Investments (2)
Gloriana Therapeutics’s most recent deal was a Seed Round with Hoba Therapeutics. The deal was made on 22-May-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hoba Therapeutics | 22-May-2019 | Seed Round | Drug Discovery | ||
| ZGene | 17-Apr-2002 | Seed Round | Biotechnology |
Gloriana Therapeutics FAQs
-
When was Gloriana Therapeutics founded?
Gloriana Therapeutics was founded in 1999.
-
Where is Gloriana Therapeutics headquartered?
Gloriana Therapeutics is headquartered in Warren, RI.
-
What is the size of Gloriana Therapeutics?
Gloriana Therapeutics has 13 total employees.
-
What industry is Gloriana Therapeutics in?
Gloriana Therapeutics’s primary industry is Biotechnology.
-
Is Gloriana Therapeutics a private or public company?
Gloriana Therapeutics is a Private company.
-
What is Gloriana Therapeutics’s current revenue?
The current revenue for Gloriana Therapeutics is .
-
How much funding has Gloriana Therapeutics raised over time?
Gloriana Therapeutics has raised $37M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process